RecruitingPhase 4NCT07190495

Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy

Preoperative Ginger for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial

Sponsor

University Tunis El Manar

Enrollment

102 participants

Start Date

Jul 5, 2025

Study Type

INTERVENTIONAL

Conditions

Postoperative nausea and vomiting Laparoscopic Cholecystectomy

Summary

This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ginger and a drug called Placebo for people with laparoscopic cholecystectomy and postoperative nausea and vomiting. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGinger

Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy

DRUGPlacebo

Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy

Locations(1)

Mohamed Taher Maamouri University Hospital

Nabeul, Nabeul Governorate, Tunisia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07190495

Related Trials

The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery

NCT075912072 locations

Ultrasound-Guided Regional Blocks for Postoperative Analgesia After Laparoscopic Cholecystectomy

NCT073216391 location

Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.

NCT070639791 location

EOIB for Pain After Laparoscopic Cholecystectomy

NCT073325461 location

Erector Spina Plane Block Versus Modified Thoracoabdominal Nerve Block After Laparoscopic Cholecystectomy

NCT076240581 location